Trajectories of self-reported pain-related health outcomes and longitudinal effects on medication use in rheumatoid arthritis: a prospective cohort analysis using the Australian Rheumatology Association Database (ARAD).
Huai Leng PisanielloSusan LesterOscar RussellRachel BlackJoanna TieuBethan RichardsClaire BarrettMarissa LassereLyn MarchRachelle BuchbinderSamuel L WhittleCatherine L HillPublished in: RMD open (2023)
In the absence of disease activity information, distinct trajectories of varying pain/health status were seen from the outset and throughout the disease course in this RA cohort. More biologic therapy modifications and greater use in anti-inflammatories, opioids and prednisolone were seen in those with poorer pain/health status, reflecting undesirable lived experience of persistent pain in RA.
Keyphrases
- rheumatoid arthritis
- disease activity
- chronic pain
- pain management
- systemic lupus erythematosus
- ankylosing spondylitis
- neuropathic pain
- rheumatoid arthritis patients
- juvenile idiopathic arthritis
- depressive symptoms
- interstitial lung disease
- emergency department
- systemic sclerosis
- mesenchymal stem cells
- health information
- adverse drug